Catalyzing a Cure: Discovery and development of LRRK2 inhibitors for the treatment of Parkinson’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Catalyzing a Cure: Discovery and development of LRRK2 inhibitors for the treatment of Parkinson’s disease

Published:2024-02 Issue: Volume:143 Page:106972
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Baidya Anurag TK,Deshwal Sonam,Das Bhanuranjan,Mathew Alen T,Devi Bharti,Sandhir Rajat,Kumar Rajnish

Funder

Indian Institute of Technology Delhi

Science and Engineering Research Board

Banaras Hindu University

Ministry of Education, India

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference90 articles.

1. Interactive Association Between Intronic Polymorphism (rs10506151) of the LRRK2 Gene and Type 2 Diabetes on Neurodegenerative Diseases;Huang;Pharmacogenomics and Personalized Medicine,2021

2. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity;Nguyen;Proceedings of the National Academy of Sciences,2020

3. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin;Greggio;Neurobiology of Disease,2006

4. Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models;Kramer;ACS Chemical Neuroscience,2012

5. LRRK2 and neurodegeneration;Santpere;Acta Neuropathologica,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model;Biomolecules;2024-06-08

2. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3